Literature DB >> 32147168

The development of 11C-carbonylation chemistry: A systematic view.

Jonas Eriksson1, Gunnar Antoni2, Bengt Långström3, Oleksiy Itsenko4.   

Abstract

The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including 11C-carbonylations and refined techniques to handle [11C]carbon monoxide at a nanomole scale. Facilitating biological research and molecular imaging was the driving force when [11C]carbon monoxide was used in the first in vivo application with carbon-11 in human (1945) and when [11C]carbon monoxide was used for the first time as a chemical reagent in the synthesis of [11C]phosgene (1978). This review examines a rich plethora of labelled compounds synthesized from [11C]carbon monoxide, their chemistry and use in molecular imaging. While the strong development of the 11C-carbonylation chemistry has expanded the carbon-11 domain considerably, it could be argued that the number of 11C-carbonyl compounds entering biological investigations should be higher. The reason for this may partly be the lack of commercially available synthesis instruments designed for 11C-carbonylations. But as this review shows, novel and greatly simplified methods to handle [11C]carbon monoxide have been developed. The next important challenge is to make full use of these technologies and synthesis methods in PET research. When there is a PET-tracer that meets a more general need, the incentive to implement 11C-carbonylation protocols will increase.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (11)C-carbonylation; Carbon monoxide; Carbon-11; PET; Positron emission tomography

Year:  2020        PMID: 32147168     DOI: 10.1016/j.nucmedbio.2020.02.005

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  4 in total

Review 1.  Radiolabeling with [11C]HCN for Positron emission tomography.

Authors:  Yu-Peng Zhou; Katarina J Makaravage; Pedro Brugarolas
Journal:  Nucl Med Biol       Date:  2021-09-25       Impact factor: 2.408

2.  In silico studies of ASEM analogues targeting α7-nAChR and experimental verification.

Authors:  Yang Zhou; Guanglin Kuang; Junhao Li; Christer Halldin; Agneta Nordberg; Bengt Långström; Yaoquan Tu; Hans Ågren
Journal:  RSC Adv       Date:  2021-01-21       Impact factor: 4.036

3.  Development of a fully automated low-pressure [11 C]CO carbonylation apparatus.

Authors:  Mélodie Ferrat; Youssef El Khoury; Peter Larsen; Kenneth Dahl; Christer Halldin; Magnus Schou
Journal:  J Labelled Comp Radiopharm       Date:  2020-08-27       Impact factor: 1.921

Review 4.  Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January-June 2020).

Authors:  Mohammed Al-Qahtani; Martin Behe; Guy Bormans; Giuseppe Carlucci; Jean Dasilva; Clemens Decristoforo; Philip H Elsinga; Klaus Kopka; Xiang-Guo Li; Robert Mach; Oskar Middel; Jan Passchier; Marianne Patt; Ivan Penuelas; Ana Rey; Peter J H Scott; Sergio Todde; Jun Toyohara; Danielle Vugts
Journal:  EJNMMI Radiopharm Chem       Date:  2021-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.